|
- Science | AAAS
The strength of Science and its online journal sites rests with the strengths of its community of authors, who provide cutting-edge research, incisive scientific commentary, and insights on what’s important to the scientific world
- Science Journal - AAAS
Science is a leading outlet for scientific news, commentary, and cutting-edge research Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million
- Argentina’s move to woo Trump has derailed South America . . . - Science
To ensure that such observing opportunities don’t go to waste, the government should issue an “immediate guarantee of [CART’s] continuity,” UNSJ’s science faculty said in a statement “The development of science has no borders,” it added, “and a cosmopolitan vision must prevail ”
- Partisan disparities in the use of science in policy
Despite recent instances of bipartisan support for science, the uncovered partisan differences in the use and trust of science highlight a profound tension at the nexus of science and politics
- James Watson: Titan of science with tragic flaws - AAAS
They thought he was trying to write a straightforward history of science, and it manifestly is not that It’s a fictionalized memoir that is almost like a social constructivist view of science, where it’s all about personality and strategy
- First approved drug for mitochondrial disease could pave way . . . - Science
“This is a very important step for mitochondrial disease physicians and patients,” says pediatric neurologist Mary Kay Koenig of the University of Texas Health Science Center at Houston The decision shows that “this is a field where treatments are approvable ”
- In vivo CAR T cell generation to treat cancer and autoimmune . . . - Science
We recently read with great interest the article by Theresa L Hunter et al , titled “In Vivo CAR T Cell Generation to Treat Cancer and Autoimmune Disease,” published in Science on June 19, 2025
- In the Pipeline by Derek Lowe | Science | AAAS
In The Pipeline Derek Lowe’s commentary on drug discovery and the pharma industry An editorially independent blog, all content is Derek’s own, and he does not in any way speak for his employer If you have any questions for Derek, please email him at derekb lowe@gmail com
|
|
|